# Bloxr

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/bloxr

- Industry: Healthcare
- Headquarters: Salt Lake City, US
- Website: www.bloxr.com
- Total disclosed funding: $1.6M
- Latest round: Series A (Dec 6, 2010)
- Investors on record: 1

## About

Bloxr develops innovative scatter radiation protection solutions, focusing on safeguarding healthcare professionals and patients during x-ray and fluoroscopy procedures through advanced material technology and custom protective apparel.Bloxr, founded in 2009 in Salt Lake City, US, specializes in manufacturing patented scatter radiation protection products. The company has completed a total of 5 deals, with the most recent being a VENTURE DEBT round in July 2014, raising USD 0.22 mn, contributing to a total amount raised of USD 3.25 mn. The CEO, Julia Jacobson, leads the company in its mission to enhance safety in clinical environments.Bloxr Solutions specializes in the manufacturing of patented scatter radiation protection products designed to safeguard clinicians and patients from exposure during medical procedures utilizing x-ray and fluoroscopy technologies. Their core products include lightweight, non-lead aprons, vests, skirts, thyroid collars, and various protective accessories such as caps, bra inserts, and arm sleeves, utilizing a patented XPF bi-layer technology for effective protection. These solutions cater to diverse medical settings including hospitals, surgical centers, dental offices, veterinary practices, and imaging facilities.Bloxr Solutions operates on a transactional revenue model, servicing a variety of clients, including hospitals and surgical centers. Revenue is generated through direct sales of specialized protective garments and accessories, with options for customization to meet specific client needs. Their flagship products, such as the BLOXR® XPF® aprons, are priced competitively based on their patented technology.Following the VENTURE DEBT financing in July 2014, Bloxr aims to accelerate its growth by developing new products and expanding market reach. The company plans to introduce additional protective gear tailored for specific medical applications and intends to expand its presence in international markets, focusing specifically on Europe and Asia by 2025. The recent funding will be utilized to support these initiatives, enhancing product development and market entry strategies.

## Funding rounds

- Series A, Dec 6, 2010, $1.6M — Pelion Venture Partners

## Investors

- Pelion Venture Partners (https://capitalatlas.ai/funds/pelion-venture-partners) — Series A